They either result from the defects in the biosynthesis of a structural protein or the posttranslational glycosylation of α-dystroglycan (also known as dystroglycanopathies) [4]. Here, DAG1 is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.